摘要
外科手术目前仍是胃肠间质瘤(GIST)病人获得根治的最佳手段,但术后复发转移是GIST病人治疗失败及死亡的主要原因。对于复发性GIST,外科治疗并不是最佳选择,应联合酪氨酸激酶抑制剂甲磺酸伊马替尼,结合病人的不同情况,个体化制定综合治疗方案,以提高病人总生存期。
Surgical resection is still the primary curative treatment for gastrointestinal stromal tumor(GIST) patients. However, postoperative recurrence and metastasis of tumors are the major causes of treatment failure and patients death. Surgery is not the best choice for recurrent GIST. It is considerable to combine surgical and molecular therapy to increase the overall survival of GIST patients.
出处
《中国实用外科杂志》
CSCD
北大核心
2010年第4期275-277,共3页
Chinese Journal of Practical Surgery
关键词
胃肠间质瘤
甲磺酸伊马替尼
gastrointestinal stromal tumor (GIST)
imatinib mesylate